VEGFA and breast carcinoma: Consistent with previous reports, we showed that Imatinib attenuates endothelial barrier dysfunction caused by the co-culture with MDA-MB-231 breast cancer cells/fibroblasts and decreased VEGF-induced endothelial permeability.